341 related articles for article (PubMed ID: 28757170)
1. The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma.
Cadamuro M; Stecca T; Brivio S; Mariotti V; Fiorotto R; Spirli C; Strazzabosco M; Fabris L
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1435-1443. PubMed ID: 28757170
[TBL] [Abstract][Full Text] [Related]
2. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
Chung BK; Karlsen TH; Folseraas T
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
[TBL] [Abstract][Full Text] [Related]
3. Targeting cholangiocarcinoma.
Mertens JC; Ilyas SI; Gores GJ
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1454-1460. PubMed ID: 28844952
[TBL] [Abstract][Full Text] [Related]
4. Chemoresistance and chemosensitization in cholangiocarcinoma.
Marin JJG; Lozano E; Herraez E; Asensio M; Di Giacomo S; Romero MR; Briz O; Serrano MA; Efferth T; Macias RIR
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1444-1453. PubMed ID: 28600147
[TBL] [Abstract][Full Text] [Related]
5. Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology.
Pinto C; Giordano DM; Maroni L; Marzioni M
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1270-1278. PubMed ID: 28754451
[TBL] [Abstract][Full Text] [Related]
6. Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness.
Brivio S; Cadamuro M; Strazzabosco M; Fabris L
World J Hepatol; 2017 Mar; 9(9):455-468. PubMed ID: 28396716
[TBL] [Abstract][Full Text] [Related]
7. Current controversies in cholangiocarcinoma.
Hoyos S; Navas MC; Restrepo JC; Botero RC
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1461-1467. PubMed ID: 28756216
[TBL] [Abstract][Full Text] [Related]
8. Bile acid receptors in the biliary tree: TGR5 in physiology and disease.
Deutschmann K; Reich M; Klindt C; Dröge C; Spomer L; Häussinger D; Keitel V
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1319-1325. PubMed ID: 28844960
[TBL] [Abstract][Full Text] [Related]
9. The search for novel diagnostic and prognostic biomarkers in cholangiocarcinoma.
Macias RIR; Banales JM; Sangro B; Muntané J; Avila MA; Lozano E; Perugorria MJ; Padillo FJ; Bujanda L; Marin JJG
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1468-1477. PubMed ID: 28782657
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of cholangiocyte responses to injury.
Sato K; Meng F; Giang T; Glaser S; Alpini G
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1262-1269. PubMed ID: 28648950
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium.
Strazzabosco M; Fiorotto R; Cadamuro M; Spirli C; Mariotti V; Kaffe E; Scirpo R; Fabris L
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1374-1379. PubMed ID: 28754453
[TBL] [Abstract][Full Text] [Related]
12. The role of tumour microenvironment: a new vision for cholangiocarcinoma.
Chen Z; Guo P; Xie X; Yu H; Wang Y; Chen G
J Cell Mol Med; 2019 Jan; 23(1):59-69. PubMed ID: 30394682
[TBL] [Abstract][Full Text] [Related]
13. Pathobiology of biliary epithelia.
Cheung AC; Lorenzo Pisarello MJ; LaRusso NF
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1220-1231. PubMed ID: 28716705
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs and extracellular vesicles in cholangiopathies.
Olaizola P; Lee-Law PY; Arbelaiz A; Lapitz A; Perugorria MJ; Bujanda L; Banales JM
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1293-1307. PubMed ID: 28711597
[TBL] [Abstract][Full Text] [Related]
15. Pathological features of primary sclerosing cholangitis identified by bile proteomic analysis.
Rupp C; Bode KA; Leopold Y; Sauer P; Gotthardt DN
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1380-1389. PubMed ID: 28943450
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: a novel in vitro model to study tumor-stroma interactions.
Massani M; Stecca T; Fabris L; Caratozzolo E; Ruffolo C; Furlanetto A; Morton S; Cadamuro M; Strazzabosco M; Bassi N
Oncol Rep; 2013 Sep; 30(3):1143-8. PubMed ID: 23807641
[TBL] [Abstract][Full Text] [Related]
17. On the role of IgG4 in inflammatory conditions: lessons for IgG4-related disease.
Trampert DC; Hubers LM; van de Graaf SFJ; Beuers U
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1401-1409. PubMed ID: 28782655
[TBL] [Abstract][Full Text] [Related]
18. Animal models of biliary injury and altered bile acid metabolism.
Mariotti V; Strazzabosco M; Fabris L; Calvisi DF
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1254-1261. PubMed ID: 28709963
[TBL] [Abstract][Full Text] [Related]
19. Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview.
Brivio S; Cadamuro M; Fabris L; Strazzabosco M
Gene Expr; 2018 Mar; 18(1):31-50. PubMed ID: 29070148
[TBL] [Abstract][Full Text] [Related]
20. The role of macrophages in the development of biliary injury in a lipopolysaccharide-aggravated hepatic ischaemia-reperfusion model.
Reiling J; Bridle KR; Schaap FG; Jaskowski L; Santrampurwala N; Britton LJ; Campbell CM; Jansen PLM; Damink SWMO; Crawford DHG; Dejong CHC; Fawcett J
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1284-1292. PubMed ID: 28709962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
